%0 Journal Article %T Checkpoint inhibitors in metastatic epidermal growth factor receptor-mutated non-small cell lung cancer patients: where we treating the wrong cancer? %A Zarogoulidis, Paul %A Papadopoulos, Vasilis %A Maragouli, Elena %A Papatsibas, George %A Huang, Haidong %J Journal of Thoracic Disease %D 2017 %B 2017 %9 %! Checkpoint inhibitors in metastatic epidermal growth factor receptor-mutated non-small cell lung cancer patients: where we treating the wrong cancer? %K %X Tyrosine kinase inhibitors (TKIs) is the best treatment choice for patients with epidermal growth factor receptor mutation (EGFR) (1). %U https://jtd.amegroups.org/article/view/15167 %V 9 %N 9 %P 2771-2773 %@ 2077-6624